Literature DB >> 10855886

Talocalcaneal coalition. Diagnosis with the C-sign on lateral radiographs of the ankle.

A Sakellariou1, D Sallomi, D L Janzen, P L Munk, R J Claridge, V A Kiri.   

Abstract

We analysed 42 weight-bearing lateral radiographs of the ankle, 20 of which were from patients with a clinical and plain radiological diagnosis of talocalcaneal coalition (TCC) who subsequently had CT. The remainder were from 22 healthy volunteers with no clinical findings suggestive of hindfoot pathology. Four observers, blinded to the CT findings, independently evaluated the radiographs on two separate occasions. With the 95% confidence interval and using the CT findings as the comparison we calculated the sensitivity, specificity, accuracy, and positive and negative predictive values for the C-sign, and for other signs known to be associated with TCC. Similarly, we also calculated the interobserver and intraobserver reliability for these signs using the kappa statistic. Our results suggest that the C-sign is highly sensitive and specific for TCC. It is an accurate indicator and significantly more reliable than other previously recognised radiological signs of TCC. Features of the C-sign, however, cannot be relied upon to indicate whether the TCC is fibrous or bony.

Entities:  

Mesh:

Year:  2000        PMID: 10855886     DOI: 10.1302/0301-620x.82b4.10263

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  2 in total

1.  A 3-portal approach for arthroscopic subtalar arthrodesis.

Authors:  Lijkele Beimers; Peter A J de Leeuw; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-04-17       Impact factor: 4.342

Review 2.  An unusual cause of ankle pain: fracture of a talocalcaneal coalition as a differential diagnosis in an acute ankle sprain: a case report and literature review.

Authors:  Dirk Wähnert; Niklas Grüneweller; Julia Evers; Anna C Sellmeier; Michael J Raschke; Sabine Ochman
Journal:  BMC Musculoskelet Disord       Date:  2013-03-26       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.